RxDoctor Payments Data

Kenneth Madsen, MD

Vascular Surgery · Boise, IDNPI 1164412862

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,863 of the $10,930 with a category attached, or 71.9%. It is spread thinly across 36 manufacturers, the largest accounting for just 22.9%. Reporting peaked in 2024 at $4,201 and has fallen 51.9% since, to $2,023 in 2025. Among vascular surgery clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,930in general payments, 2019–2025

Across 139 payments — averaging $78.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$3K
  • Medtronic$2K
  • Silk Road Medical, Inc.$2K
  • Boston Scientific$1K
  • Globus Medical$794
  • Shockwave Medical, Inc$532
  • plus $3K from 30 others

What the payments were for

  • Travel & lodging$3,06628%
  • Food & beverage$7,86372%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,930 in reported general payments places this provider in the 90th percentile of 28 vascular surgery providers in Idaho.

See all vascular surgery providers in Idaho

Medicare billing

Part B allowed, 2024
$101,071
Medicare patients
367
Services billed
932

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban12$10,994
ClopidogrelClopidogrel Bisulfate102$543
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$180
Atorvastatin Calcium28$90

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$12$10,99412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 28 vascular surgery providers in Idaho.

Other vascular surgery in Boise

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →